PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care.

$2.89  +0.04 (1.40%)
As of 06/27/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/11/2012
Outstanding shares:  44,973,141
Average volume:  676,691
Market cap:   $128,173,452
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B7F2TY6
Valuation   (See tab for details)
PE ratio:   -2.62
PB ratio:   17.92
PS ratio:   0.64
Return on equity:   -686.59%
Net income %:   -24.44%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy